Aralez Pharmaceuticals Inc. 4
4 · Aralez Pharmaceuticals Inc. · Filed Feb 9, 2016
Insider Transaction Report
Form 4
Charles Scott J
Chief Financial Officer
Transactions
- Other
Common Shares
2016-02-05+29,137→ 29,137 total
Footnotes (2)
- [F1]Reflects the beneficial ownership of the reporting person following consummation of the business transaction among POZEN Inc. ("Pozen"), Tribute Pharmaceuticals Canada Inc. ("Tribute") and the Registrant on February 5, 2016, pursuant to the Agreement and Plan of Merger and Arrangement as entered into on June 8, 2015 and as amended on August 19, 2015 and December 7, 2015 among Pozen, Tribute, the Registrant, Aralez Pharmaceuticals Holdings Limited, ARLZ US Acquisition II Corp., and ARLZ CA Acquisition Corp. (the "Merger").
- [F2]Represents 29, 137 shares issuable pursuant to Restricted Stock Units previously granted by Pozen, predecessor to the Registrant.